Related Experiment Video
Updated: Aug 8, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Nevirapine toxicity
1Division of Infectious Diseases, Northwestern University Medical School, Chicago, IL 60611, USA. b-taiwo@northwestern.edu
International Journal of STD & AIDS
|June 1, 2006
Summary
Nevirapine toxicity, including skin and liver issues, is rising in HIV patients. Careful dosing and monitoring are crucial, especially for women with high CD4 counts, to reduce risks.
Area of Science:
- Pharmacology
- Infectious Diseases
- Toxicology
Background:
- Increasing global use of nevirapine in HIV-infected patients.
- Nevirapine is associated with significant cutaneous and hepatic toxicities.
- These toxicities are more frequent compared to efavirenz.
Purpose of the Study:
- To highlight the increasing incidence of nevirapine toxicity in HIV patients.
- To emphasize the importance of adhering to dosing guidelines and recognizing toxicities.
- To identify patient groups with increased susceptibility to nevirapine toxicity.
Main Methods:
- Clinical observation and data review on nevirapine toxicity.
- Comparative analysis of nevirapine versus efavirenz toxicity profiles.
- Identification of risk factors, including CD4 counts and patient demographics.
Main Results:
- Nevirapine toxicities (cutaneous, hepatic) are common and increasing.
- Women with CD4 counts >250 cells/mm3 show heightened susceptibility.
- Nevirapine exhibits higher toxicity rates than efavirenz.
Conclusions:
- Strict adherence to nevirapine dosing and toxicity recognition is essential.
- Risk stratification is needed, particularly for women with high CD4 counts.
- Further research into pathogenesis, pharmacokinetics, and genetics will improve nevirapine safety.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Related Concept Videos
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...